Structures by: Bibila Mayaya Bisseyou Y. V.
Total: 8
Coumarin-102
C16H17NO2
Acta Crystallographica Section B (2012) 68, 6 646-660
a=8.5755(3)Å b=10.1627(3)Å c=14.2676(2)Å
α=90.00° β=95.249(2)° γ=90.00°
1-(2,7-Dimethylimidazo[1,2-<i>a</i>]pyridin-3-yl)-2-(1,3-dithiolan-2-ylidene)ethanone monohydrate
C14H14N2OS2,H2O
Acta Crystallographica Section E (2019) 75, 12 1934-1939
a=28.3247(7)Å b=28.3247(7)Å c=7.2820(2)Å
α=90° β=90° γ=90°
Methyl (1<i>H</i>-benzimidazol-2-ylsulfanyl)acetate
C10H10N2O2S
Acta Crystallographica Section E (2007) 63, 10 o3987-o3987
a=9.337(9)Å b=13.418(15)Å c=9.667(8)Å
α=90° β=116.04(7)° γ=90°
3-(3-Chlorophenyl)-1-(2-methylimidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one
C17H13Cl1N2O1
Acta Crystallographica Section E (2007) 63, 12 o4758-o4759
a=4.784(2)Å b=21.690(2)Å c=13.773(9)Å
α=90° β=93.425(4)° γ=90°
1-(2-Methylimidazo[1,2-<i>a</i>]pyridin-3-yl)-3,3-bis(methylsulfanyl)prop- 2-enone monohydrate
C13H14N2OS2,H2O
Acta Crystallographica Section E (2009) 65, 7 o1698-o1699
a=5.14050(10)Å b=17.7653(3)Å c=31.3919(6)Å
α=90° β=90° γ=90°
2-[2-(4-Methoxyphenyl)-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-4-yl]phenol
C22H20N2O2
Acta Crystallographica Section E (2010) 66, 1 o87-o88
a=27.5064(5)Å b=7.3811(2)Å c=19.5038(4)Å
α=90° β=117.699(2)° γ=90°
Ethyl 4-cyano-7-nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-<i>a</i>]quinoline-4- carboxylate
C16H17N3O4
Acta Crystallographica Section E (2012) 68, 2 o550-o551
a=7.2292(2)Å b=9.1589(3)Å c=11.8243(5)Å
α=79.3320(10)° β=82.6090(10)° γ=80.429(2)°
2-Oxo-2<i>H</i>-chromen-4-yl propionic acid
C12H10O4
Acta Crystallographica Section E (2013) 69, 7 o1125-o1126
a=9.2834(3)Å b=6.7081(2)Å c=16.8068(6)Å
α=90.00° β=90.00° γ=90.00°